search
Back to results

Comparison of Stellaris Standard Infusion With Stellaris Elite

Primary Purpose

Cataract

Status
Unknown status
Phase
Not Applicable
Locations
Austria
Study Type
Interventional
Intervention
Stellaris Elite
Sponsored by
Prim. Prof. Dr. Oliver Findl, MBA
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Cataract focused on measuring Cataract, Cataract surgery, Phacoemulsification platform

Eligibility Criteria

21 Years - 105 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age-related cataract in both eyes
  • Scheduled for bilateral cataract surgery
  • Myopic patiens with axial eye length >25.0mm
  • Age 21 and older
  • Written informed consent prior to recruitment

Exclusion Criteria:

  • Pregnancy (pregnancy test will be taken pre-operatively in women of reproductive age)
  • Preceded ophthalmic surgery
  • Any ophthalmic abnormality that could compromise the measurements
  • Concurrent participation in another drug or device clinical investigation

Sites / Locations

  • Vienna Institute for Research in Ocular Surgery (VIROS)Recruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Myopic patients

Arm Description

In myopic patients with axial length over 25.0 mm during surgery of the first eye the Stellaris platform will be used and during surgery of the second eye the Stellaris Elite platform will be used

Outcomes

Primary Outcome Measures

Anterior chamber depth
Anterior chamber depth will be measured using the IOL Master 700. Fluctuations in anterior chamber depth will be compared between the eyes where Stellaris and the contralateral eyes in which the Stellaris Elite platform was used

Secondary Outcome Measures

Patients discomfort
Patients will be asked concerning their discomfort during both cataract surgeries and results will be recorded using an visual analogue scale. In the visual analogue scale 10 means highest discomfort and 1 stands for lowest discomfort.

Full Information

First Posted
November 21, 2018
Last Updated
November 21, 2018
Sponsor
Prim. Prof. Dr. Oliver Findl, MBA
search

1. Study Identification

Unique Protocol Identification Number
NCT03751254
Brief Title
Comparison of Stellaris Standard Infusion With Stellaris Elite
Official Title
Comparison of Phacoemulsification Platform Stellaris With Standard Infusion and Stellaris Elite With Pressurised Bottle in Myopic Eyes Concerning Deepening of Anterior Chamber as Measured by Intra-operative OCT
Study Type
Interventional

2. Study Status

Record Verification Date
November 2018
Overall Recruitment Status
Unknown status
Study Start Date
October 1, 2018 (Actual)
Primary Completion Date
December 1, 2019 (Anticipated)
Study Completion Date
December 1, 2019 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Prim. Prof. Dr. Oliver Findl, MBA

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Clinical performance of phacoemulsification platform Stellaris Elite with standard irrigation fluid bottles in myopic eyes. Anterior chamber depth and patients comfort will be compared between the two groups.
Detailed Description
Today phacoemulsification is the most important and safest procedure to perform cataract surgery. However, there are factors that can increase the risk of complications, one of them is an intraoperative increase of intraocular pressure (IOP) which may cause choroidal haemorrhage, capsular block syndrome, or posterior capsular rupture . Also, more regularly, alterations of IOP provoke sudden changes of the anterior chamber depth, especially in myopic eyes due to intra-operative inverse irido-capsular block, which may result in pain or discomfort for the patient. The deepening of the chamber also makes the surgical maneuvers more challenging in such eyes. As prevention of such adverse events, it is important to maintain a more or less constant IOP intraoperatively. To ensure this, the pressure of the irrigation fluid must be adjusted to the outflow of aqueous humor, usually by adapting the height of the irrigation fluid bottle (passive fluidics system). As a variable vacuum is produced at the phaco tip to enable the suction of lens fragments, there often are fluctuations of IOP, therefore the surgeon is required to constantly adjust the height of the irrigation fluid bottle. A novel method to relieve the surgeon of this often-distracting task is to use all-in-one phacoemulsification systems that are able to monitor vacuum flow rates and then adjust the pressure of the irrigation fluid intraoperatively, also resulting in less fluctuations of IOP (active fluidics system). This should also result in reduced deepening of the anterior chamber and less risk of the adverse events as explained above.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cataract
Keywords
Cataract, Cataract surgery, Phacoemulsification platform

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
35 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Myopic patients
Arm Type
Experimental
Arm Description
In myopic patients with axial length over 25.0 mm during surgery of the first eye the Stellaris platform will be used and during surgery of the second eye the Stellaris Elite platform will be used
Intervention Type
Device
Intervention Name(s)
Stellaris Elite
Intervention Description
The Stellaris and the Stellaris Elite platform will be used in myopic patients (axial length > 25.0 mm) during cataract surgery
Primary Outcome Measure Information:
Title
Anterior chamber depth
Description
Anterior chamber depth will be measured using the IOL Master 700. Fluctuations in anterior chamber depth will be compared between the eyes where Stellaris and the contralateral eyes in which the Stellaris Elite platform was used
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Patients discomfort
Description
Patients will be asked concerning their discomfort during both cataract surgeries and results will be recorded using an visual analogue scale. In the visual analogue scale 10 means highest discomfort and 1 stands for lowest discomfort.
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
105 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age-related cataract in both eyes Scheduled for bilateral cataract surgery Myopic patiens with axial eye length >25.0mm Age 21 and older Written informed consent prior to recruitment Exclusion Criteria: Pregnancy (pregnancy test will be taken pre-operatively in women of reproductive age) Preceded ophthalmic surgery Any ophthalmic abnormality that could compromise the measurements Concurrent participation in another drug or device clinical investigation
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Kristina Stjepanek, MD
Phone
01 91021-57564
Email
office@viros.at
First Name & Middle Initial & Last Name or Official Title & Degree
Julius Hienert, MD
Phone
01 91021-57564
Email
office@viros.at
Facility Information:
Facility Name
Vienna Institute for Research in Ocular Surgery (VIROS)
City
Vienna
ZIP/Postal Code
1140
Country
Austria
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kristina Stjepanek, MD
Phone
01 910 21-57564
Email
office@viros.at
First Name & Middle Initial & Last Name & Degree
Julius Hienert, MD
Phone
01 91021-57564
Email
office@viros.at

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Comparison of Stellaris Standard Infusion With Stellaris Elite

We'll reach out to this number within 24 hrs